Skip to main content

Advertisement

Table 3 Antibiotic susceptibility rates according to the occurrence of severe complications attributable to viridans streptococcal bacteremia

From: Clinical characteristics and antimicrobial susceptibilities of viridans streptococcal bacteremia during febrile neutropenia in patients with hematologic malignancies: a comparison between adults and children

Antibiotics All patients* (n=201) Without complications (n=175) With complications (n=26) p-value
Penicillin 79/201 (39.3) 70/175 (40.0) 9/26 (34.6) 0.600
Cefotaxime 166/200 (83.0) 142/174 (81.6) 24/26 (92.3) 0.263
Cefepime 159/199 (79.9) 136/173 (78.6) 23/26 (88.5) 0.243
Vancomycin 201/201 (100.0) 175/175 (100.0) 26/26 (100.0) NA
Linezolid 200/201 (99.5) 174/175 (99.4) 26/26 (100.0) 1.000
Clindamycin 172/201 (85.6) 151/175 (86.3) 21/26 (80.8) 0.548
Erythromycin 99/201 (49.3) 86/175 (49.1) 13/26 (50.0) 0.935
  1. Data are No. (%) of cases.
  2. NA not available.
  3. *Antibiotic susceptibility tests were performed in 201 patients (175 without severe complications, 26 with severe complications).
  4. Antibiotic susceptibility tests were performed in 200 patients (174 without severe complications, 26 with severe complications).
  5. Antibiotic susceptibility tests were performed in 199 patients (173 without severe complications, 26 with severe complications).